INHIBIKASE THERAPEUTICS INC (IKT) Stock Cash Flow
NASDAQ:IKT - Nasdaq - US45719W2052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -36.55M | -27.52M | -19.03M | -18.05M | -14.79M | |||
| Depreciation Amortization | 32.40K | 26.30K | 177.40K | 10.00K | N/A | |||
| Change In Working Capital | 810.20K | 204.90K | 234.80K | 170.00K | -1.76M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 16.32M | 8.14M | 531.70K | 530.00K | 2.25M | |||
| OPERATING CASH FLOW | -19.38M | -19.15M | -18.09M | -17.35M | -14.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -14.20K | -240.00K | N/A | |||
| Other Investing Activity | -12.19M | -37.00M | 11.67M | -15.76M | N/A | |||
| INVESTING CASH FLOW | -12.64M | -37.00M | 11.66M | -16.01M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -250.00K | -40.00K | |||
| Stock Issued/Repurchased | 103.08M | 103.48M | 8.54M | 40.00K | 41.21M | |||
| Other Financing Activity | N/A | 0.00 | -138.60K | 0.00 | -80.00K | |||
| FINANCING CASH FLOW | 103.11M | 103.48M | 8.40M | -200.00K | 41.09M | |||
| CHANGE IN CASH | 71.09M | 47.33M | 1.98M | -33.56M | 26.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.38M | -19.15M | -18.09M | -17.35M | -14.30M | |||
| Capital Expenditure | N/A | 0.00 | -14.20K | -240.00K | N/A | |||
| FREE CASH FLOW | -19.84M | -19.15M | -18.10M | -17.59M | -14.30M | |||
All data in USD